Selected research
Market Structure
Global Amphetamine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Amphetamine Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amphetamine Drug include Novartis, Eli Lilly, Pfizer, GSK, Purdue Pharma and Hisamitsu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amphetamine Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amphetamine Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amphetamine Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amphetamine Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Amphetamine Drug Segment by Company
Novartis
Eli Lilly
Pfizer
GSK
Purdue Pharma
Hisamitsu Pharmaceutical
Amphetamine Drug Segment by Type
Adult
Children
Amphetamine Drug Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Amphetamine Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amphetamine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amphetamine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amphetamine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amphetamine Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amphetamine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amphetamine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amphetamine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Adult
- Children
Applications
- Retail Pharmacy
- Hospital Pharmacy
- Other
Companies covered
- Novartis
- Eli Lilly
- Pfizer
- GSK
- Purdue Pharma
- Hisamitsu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amphetamine Drug Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amphetamine Drug Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amphetamine Drug Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amphetamine Drug Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amphetamine Drug Market Dynamics
- 2.1 Amphetamine Drug Industry Trends
- 2.2 Amphetamine Drug Industry Drivers
- 2.3 Amphetamine Drug Industry Opportunities and Challenges
- 2.4 Amphetamine Drug Industry Restraints
3 Amphetamine Drug Market by Manufacturers
- 3.1 Global Amphetamine Drug Revenue by Manufacturers (2021-2026)
- 3.2 Global Amphetamine Drug Sales by Manufacturers (2021-2026)
- 3.3 Global Amphetamine Drug Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amphetamine Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amphetamine Drug Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amphetamine Drug Manufacturers, Product Type & Application
- 3.7 Global Amphetamine Drug Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amphetamine Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amphetamine Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Amphetamine Drug Tier 1, Tier 2, and Tier 3
4 Amphetamine Drug Market by Type
- 4.1 Amphetamine Drug Type Introduction
- 4.1.1 Adult
- 4.1.2 Children
- 4.2 Global Amphetamine Drug Sales by Type
- 4.2.1 Global Amphetamine Drug Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amphetamine Drug Sales by Type (2021-2032)
- 4.2.3 Global Amphetamine Drug Sales Market Share by Type (2021-2032)
- 4.3 Global Amphetamine Drug Revenue by Type
- 4.3.1 Global Amphetamine Drug Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amphetamine Drug Revenue by Type (2021-2032)
- 4.3.3 Global Amphetamine Drug Revenue Market Share by Type (2021-2032)
5 Amphetamine Drug Market by Application
- 5.1 Amphetamine Drug Application Introduction
- 5.1.1 Retail Pharmacy
- 5.1.2 Hospital Pharmacy
- 5.1.3 Other
- 5.2 Global Amphetamine Drug Sales by Application
- 5.2.1 Global Amphetamine Drug Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amphetamine Drug Sales by Application (2021-2032)
- 5.2.3 Global Amphetamine Drug Sales Market Share by Application (2021-2032)
- 5.3 Global Amphetamine Drug Revenue by Application
- 5.3.1 Global Amphetamine Drug Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amphetamine Drug Revenue by Application (2021-2032)
- 5.3.3 Global Amphetamine Drug Revenue Market Share by Application (2021-2032)
6 Global Amphetamine Drug Sales by Region
- 6.1 Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amphetamine Drug Sales by Region (2021-2032)
- 6.2.1 Global Amphetamine Drug Sales by Region (2021-2026)
- 6.2.2 Global Amphetamine Drug Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amphetamine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amphetamine Drug Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amphetamine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amphetamine Drug Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amphetamine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amphetamine Drug Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amphetamine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amphetamine Drug Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amphetamine Drug Revenue by Region
- 7.1 Global Amphetamine Drug Revenue by Region
- 7.1.1 Global Amphetamine Drug Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amphetamine Drug Revenue by Region (2021-2026)
- 7.1.3 Global Amphetamine Drug Revenue by Region (2027-2032)
- 7.1.4 Global Amphetamine Drug Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amphetamine Drug Revenue (2021-2032)
- 7.2.2 North America Amphetamine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amphetamine Drug Revenue (2021-2032)
- 7.3.2 Europe Amphetamine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amphetamine Drug Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amphetamine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amphetamine Drug Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amphetamine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Amphetamine Drug Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Company Information
- 8.2.2 Eli Lilly Business Overview
- 8.2.3 Eli Lilly Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eli Lilly Amphetamine Drug Product Portfolio
- 8.2.5 Eli Lilly Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Amphetamine Drug Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 GSK
- 8.4.1 GSK Company Information
- 8.4.2 GSK Business Overview
- 8.4.3 GSK Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GSK Amphetamine Drug Product Portfolio
- 8.4.5 GSK Recent Developments
- 8.5 Purdue Pharma
- 8.5.1 Purdue Pharma Company Information
- 8.5.2 Purdue Pharma Business Overview
- 8.5.3 Purdue Pharma Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Purdue Pharma Amphetamine Drug Product Portfolio
- 8.5.5 Purdue Pharma Recent Developments
- 8.6 Hisamitsu Pharmaceutical
- 8.6.1 Hisamitsu Pharmaceutical Company Information
- 8.6.2 Hisamitsu Pharmaceutical Business Overview
- 8.6.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
- 8.6.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amphetamine Drug Value Chain Analysis
- 9.1.1 Amphetamine Drug Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amphetamine Drug Production Mode & Process
- 9.2 Amphetamine Drug Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amphetamine Drug Distributors
- 9.2.3 Amphetamine Drug Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst